Rutgers Racing to Discover a Better Paxlovid
January 10, 2024
January 10, 2024
NEW BRUNSWICK, New Jersey, Jan. 10 (TNSres) -- Rutgers University issued the following news:
By Andrew Smith
Researchers from Rutgers are among leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid - the antiviral medication that helps keep high-risk patients out of the hospital and from dying.
They have published data showing that an alternative medication, a viral papain-like protease inhibitor, inhibits disease progressio . . .
By Andrew Smith
Researchers from Rutgers are among leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid - the antiviral medication that helps keep high-risk patients out of the hospital and from dying.
They have published data showing that an alternative medication, a viral papain-like protease inhibitor, inhibits disease progressio . . .